Below are the financial statements of Dexcom, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 4,033a | 3,622.3a | 2,909.8a |
| Cost of sales | -1,594.8a | -1,333.4a | -1,026.7a |
| Gross profit | 2,438.2a | 2,288.9a | 1,883.1a |
| Operating expenses | — | — | — |
| Research and development | -552.4a | -505.8a | -484.2a |
| Selling, general and administrative | -1,285.8a | -1,185.4a | -1,007.7a |
| Total operating expenses | -1,838.2a | -1,691.2a | -1,491.9a |
| Operating income | 600a | 597.7a | 391.2a |
| Other income (expense), net | 109a | 112.7a | -0.4a |
| Income before income taxes | 709a | 710.4a | 390.8a |
| Income tax expense | -132.8a | -168.9a | -49.6a |
| Net income | 576.2a | 541.5a | 341.2a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Dexcom’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.